Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Simulations Plus has received a purchase order from the FDA to license the company's ADMET Predictor software.
Subscribe to our email newsletter
Ron Creeley, vice president of marketing and sales for Simulations Plus, said: “We’re very pleased that the FDA’s cardiovascular and renal products division has licensed our ADMET Predictor software with all four of its modules.
“ADMET Predictor predicts almost 80 properties of molecules with only their molecular structure as input, including physicochemical, biopharmaceutical, metabolism, toxicity and some activity properties. The program has been consistently ranked first in accuracy in published comparison studies with competitive programs.”